This page contains recent news articles, when available, and an overview of but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Background information on

New Chronic Myelogenous Leukemia Guidelines Add Nilotinib  -  Mar 17, 2008
Medscape (subscription)...to imatinib in the treatment of chronic myelogenous leukemia as presented at the National Comprehensive Cancer Network 13th Annual Conference.

Flow Cytometry and Molecular Genetics for Hematologic Neoplasms  -  Mar 21, 2008
Medscape (subscription)For the diagnosis of chronic myelogenous leukemia (CML), the detection of BCR/ABL translocation by fluorescence in situ hybridization (FISH) is an absolute

QUICK SEARCH BY ORGANIZATION  -  Mar 3, 2008
Canada NewsWire (press release),About the CML (Chronic Myelogenous Leukemia) Society of Canada Established in 2006, the CML (Chronic Myelogenous Leukemia) Society provides support,

InvestBio Portfolio Company Presents Phase I/II Trial Results of ...  -  Feb 29, 2008
Earthtimes,T lymphocytes that selectively kill three types of leukemia - myelodysplastic syndrome, acute myelogenous leukemia and chronic myelogenous leukemia.

Leafs Notebook: Blake nominated for Masterton Trophy  -  Mar 7, 2008
National Post,During training camp, the Maple Leafs forward was diagnosed with chronic myelogenous leukemia, a rare but treatable form of cancer.

Late-season playoff push nothing but a tease  -  Mar 8, 2008
Globe and Mail,...the Professional Hockey Writers Association because of his season-long battle with chronic myelogenous leukemia, a rare, but treatable form of cancer.

Leaf Blake chosen as Masterton nominee  -  Mar 8, 2008
Toronto Star,Blake discovered his condition – chronic myelogenous leukemia (CML) – less than two weeks into the regular season. It was on Oct.9, that Blake made the

NHL: Leafs' Blake feels 'lucky' five months after diagnosis  -  Mar 9, 2008
National Post,Blake was diagnosed with chronic myelogenous leukemia in October, but has become one of only four players to take part in each of Toronto’s 70 games this

Pregnant CML Patients Face Congenital Dilemma with Imatinib (Gleevec)  -  Mar 7, 2008
MedPage Today,By Charles Bankhead, Staff Writer, MedPage Today LONDON, March 7 -- Pregnancy during therapy for chronic myelogenous leukemia puts women in a

... Go to the Article  -  Mar 3, 2008
CancerWiseT lymphocytes are produced that selectively kill three types of leukemia: MDS, acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML).

Blake's perseverance Masterton-worthy  -  Mar 8, 2008
Toronto Sun,Blake has chronic myelogenous leukemia, a rare, but treatable form of the disease and must take a daily pill called Gleevec for his condition.

Otsuka Pharmaceutical and PDL BioPharma Close Sale of IV Busulfex  -  Mar 10, 2008
CNNMoney.com...hematopoietic progenitor cell transplantation (also referred to as blood or bone marrow transplantation or BMT) for chronic myelogenous leukemia (CML).

Genetic Cancer Link Between Humans And Dogs Discovered  -  Feb 28, 2008
Science Daily (press release)...including chronic myelogenous leukemia (CML), Burkitt's lymphoma (BL), and chronic lymphocytic leukemia (CLL), are virtually identical to genetic

(2º) Financial Results  -  Mar 20, 2008
InfoBolsa,...include c-KIT in gastrointestinal stromal tumors, epidermal growth factor receptor (EGFR) in lung cancer, and BCR-ABL in chronic myelogenous leukemia.

Targeted Therapies: A New Generation of Cancer Treatments  -  Mar 6, 2008
RedOrbit,Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia [published correction appears in N Engl J Med.

Ambit Biosciences Announces the Formation of Two Clinical Advisory ...  -  Feb 28, 2008
Business Wire (press release),Dr. Druker’s work was instrumental in the development of the BCR-ABL kinase inhibitor imatinib (Gleevec) for the treatment of chronic myelogenous leukemia

NMBio Announces the 2008 Board of Directors  -  Feb 29, 2008
Earthtimes,...lead to the introduction of Glivec, the first specific treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST).

SGX Pharmaceuticals Announces Fourth Quarter and Full Year ...  -  Mar 12, 2008
Biloxi Sun Herald,...(as well as other resistant mutants and wild-type BCR-ABL) and is likely most applicable to relapsed/refractory chronic myelogenous leukemia (CML).

Meds can do good ... if you take them  -  Feb 24, 2008
Chicago Daily Herald,...summoned him from his home in Brownsville, Texas, saying his latest lab results indicated his disease -- chronic myelogenous leukemia -- had returned.

Cancer Institute lands $5M  -  20 Feb 2008
Bizjournals.com,Mills, who has chronic myelogenous leukemia, has been successfully treated with the Druker-developed drug Gleevec since 2001.

So, What Is Leukemia Anyway?  -  Feb 12, 2008
Daily Norseman,Chronic myeloid leukemia (chronic myelogenous leukemia, CML) accounts for about 4400 new cases of leukemia each year. It affects mainly adults.

Community rallies around young transplant patient  -  Feb 7, 2008
Daytona Beach News-Journal,Eventually, doctors would diagnose Jessica with chronic myelogenous leukemia, a slow-growing cancer of the white blood cells. "It's very rare in children,"

Bout with leukemia teaches Sterett a lesson  -  Feb 15, 2008
Augusta Chronicle (subscription),He was diagnosed with chronic myelogenous leukemia. Keith was told 98 kids across America are found with that each year. His survival rate was right at 70

We Will Take Your Money and Run...  -  Jan 24, 2008
NewsBlaze,My mother was diagnosed with chronic myelogenous leukemia when she was 28 years old. This rare form of leukemia could only be cured with a bone marrow

Cytokinetics, Incorporated Reports Fourth Quarter and Year End ...  -  Feb 1, 2008
FOXBusiness...cycle to adult patients with relapsed or refractory acute leukemias, chronic myelogenous leukemia in blast crisis or advanced myelodysplastic syndromes.

Congress tampering with doctor-patient relationship  -  Feb 10, 2008
The Tennessean,Gleevec for chronic myelogenous leukemia; Sutent for kidney cancer; numerous Alzheimer's medicines for early to mid-stage treatment of the illness;

Chicago artist blew past societal roadblocks  -  Feb 8, 2008
South Bend Tribune,21, 2003, from complications from chronic myelogenous leukemia. By the time of his death at the age of 40, Willis had produced more than 100 albums and

Treatment for Chronic Myelogenous Leukemia  -  Dec 15, 2007
DentalPlans.com,After a person is diagnosed with Chronic Myelogenous Leukemia, or CML, the first goal of treatment is to normalize blood counts. This means taking a drug to

Understanding Chronic Myelogenous Leukemia  -  Dec 15, 2007
DentalPlans.com,CML is a cancer of the blood. In people with CML, there is a disruption in the process that governs the normal life cycle of white blood cells.

Data Confirm Dasatinib’s Effectiveness in Resistant Chronic ...  -  Dec 11, 2007
Newswise (press release)...continues to be highly effective in patients with chronic myelogenous leukemia who were unable to tolerate Gleevec or who developed resistance to it,

Vaccine Improves Event-free Survival For Leukemia Patients  -  Dec 10, 2007
Science Daily (press release)Disease-specific Phase II clinical trials of the vaccine for chronic myelogenous leukemia and myelodysplastic syndrome are planned or under way at MD

IVPH: Presents Ph I Data Today re INNO-406 for Chronic Myelogenous ...  -  Dec 10, 2007
Trading Markets (press release),Phase I study of its drug candidate INNO-406, a potent, oral, dual Bcr-Abl and Lyn-kinase inhibitor in patients with Chronic Myelogenous Leukemia (CML).

Discovery Opens New Window To Understanding Chronic Myeloid Leukemia  -  Dec 10, 2007
Science Daily (press release)Chronic myelogenous leukemia is a form of blood cancer characterized by the increased and unregulated growth of predominantly myeloid cells in the bone

Data from INNOVIVE Pharmaceuticals’ Oncology Drug Programs to be ...  -  Dec 5, 2007
Business Wire (press release),INNO-406, an orally bioavailable dual Bcr-Abl and Lyn-kinase inhibitor for Gleevec resistant or intolerant chronic myelogenous leukemia, and INNO-305,

Major Clinical Cancer Advances in 2007  -  Dec 27, 2007
Medscape (subscription)Dasatinib (Sprycel, Bristol-Myers Squibb) active as first-line treatment for chronic myelogenous leukemia. Lenalidomide (Revlimid, Celgene Corp) and

Blake returns, hears boos from Islander fans  -  Dec 27, 2007
Newsday,That is literally healthy, what with people well aware that Blake is fit and vibrant, thanks to medication for the chronic myelogenous leukemia with which

Dasatinib and Nilotinib Show Strong Early Results as Frontline ...  -  Dec 9, 2007
Newswise (press release)Newswise — Two drugs approved for use as second line therapy for chronic myelogenous leukemia are showing promising results as frontline therapy for newly

INNOVIVE Pharmaceuticals Presents Preliminary Data at ASH Showing ...  -  Dec 8, 2007
Business Wire (press release),...for the treatment of chronic myelogenous leukemia, acute promyelocytic leukemia, small cell lung cancer, and acute myelogenous leukemia, respectively.

Leukemia vaccine dramatically improves event-free survival in trials  -  Dec 9, 2007
Thaindian.com,The vaccine selectively kills three types of leukemia - myelodysplastic syndrome, acute myelogenous leukemia and chronic myelogenous leukemia.

Company run by Iranian-American on Time Magazine's top ten list  -  Dec 27, 2007
Payvand,...which determines whether white blood cells from patients with chronic myelogenous leukemia (CML) are sensitive or resistant to imatinib, the therapy of

Photo: New Data Show Gleevec(R) Halts Progression to Advanced ...  -  Dec 9, 2007
CNNMoney.comBesa, Emmanuel C. Chronic Myelogenous Leukemia. E-Medicine, WebMD. Available at: http://www.emedicine.com/med/topic371.htm. Accessed 30 November, 2007. 4.

Nilotinib Response Rates Continue To Improve In Patients With ...  -  Dec 13, 2007
Medical News Today (press release),Kantarjian, H. Nilotinib is Highly Active and Safe in Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Patients with Imatinib-resistance or Intolerance.

Bristol-Myers Squibb Media Fact-Sheet at The American Society of ...  -  Dec 11, 2007
PharmiWeb.com (press release),Efficacy of Dasatinib in Patients with Chronic-phase Chronic Myelogenous Leukemia with Resistance or Intolerance to Imatinib: 2-year Follow-up Data from

SGX Pharmaceuticals BCR-ABL Program to be Presented at the ...  -  Dec 6, 2007
CNNMoney.com...program for the treatment of chronic myelogenous leukemia (CML) at the upcoming American Society of Hematology's 49th Annual Meeting and Exposition.

Bristol, Novartis Bid to Replace Gleevec for Leukemia (Update1)  -  Dec 10, 2007
BloombergBristol-Myers' Sprycel eliminated any trace of disease among all 24 patients with chronic myelogenous leukemia for one year, according to research presented

Two-Year Data on Dasatinib Shows Continued Benefit in Patients ...  -  Dec 12, 2007
DG News...[Presentation title: Efficacy of Dasatinib in Patients With Chronic-Phase Chronic Myelogenous Leukemia With Resistance or Intolerance to Imatinib: 2-Year

Cord Blood Stem Cell Expansion: Increasing The Yield Of A Valuable ...  -  Dec 20, 2007
Medical News Today (press release),3 - At Hackensack University Medical Center in Hackensack, New Jersey, two adults with chronic myelogenous leukemia exhibited rapid engraftment after

New Data Show Glivec® Halts Progression to Advanced Stages of Life ...  -  Dec 10, 2007
DG NewsThe biology of chronic myeloid leukemia. N Engl J Med. 341:164-72, 1999. 3. Besa, Emmanuel C. Chronic Myelogenous Leukemia. E-Medicine, WebMD. Available at:

Otsuka Pharma acquires rights to IV Busulfex from PDL BioPharma ...  -  Dec 17, 2007
CNNMoney.com...in 1999 for use in combination with cyclophosphamide as a conditioning regimen prior to bone marrow transplants for chronic myelogenous leukemia.

Otsuka Pharmaceutical Acquires Rights to IV Busulfex from PDL ...  -  Dec 17, 2007
CNNMoney.com...hematopoietic progenitor cell transplantation (also referred as blood or bone marrow transplantation or BMT) for chronic myelogenous leukemia (CML).

Immunomedics Develops New Interferon Product Using Dock-and-Lock  -  Dec 10, 2007
CNNMoney.com...it is indicated for the therapy of hairy cell leukemia, chronic myelogenous leukemia, follicular lymphoma, and malignant melanoma.

Another ‘Smart’ Cancer Drug Can Have Toxic Effects on the Heart  -  Dec 25, 2007
Ivanhoe,...imitinib, was reported last year in Nature Medicine, to be associated with heart failure in patients with chronic myelogenous leukemia.

Innovative Research Provides Insight Into Improving the Treatment ...  -  Dec 9, 2007
Earthtimes,...including acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic-phase chronic myelogenous leukemia (CML), will be presented

Dasatinib's Bleeding Complications Confirmed, Explained: Presented ...  -  Dec 12, 2007
DG News...[Presentation title: Dasatinib-Induced Platelet Dysfunction; Bleeding Diathesis in Patients (pts) With Chronic Myelogenous Leukemia Receiving Dasatinib

Early Phase II results show bosutinib safe, effective for CML  -  Dec 11, 2007
EurekAlert (press release),ATLANTA - A new drug for chronic myelogenous leukemia works for patients who have developed resistance to frontline therapy and causes fewer side effects

Another 'Smart' Cancer Drug Can Have Toxic Effects On The Heart ...  -  Dec 14, 2007
Science Daily (press release)Novartis Pharmaceuticals), was reported last year in Nature Medicine to be associated with heart failure in patients with chronic myelogenous leukemia.

Meet your match  -  Dec 23, 2007
SunJournal.com (subscription),..."Bone marrow transplant is a life-threatening procedure," says Chip Morrison, whose son Brett has chronic myelogenous leukemia and considered a transplant.

He's a runner on a mission  -  Dec 12, 2007
Cincinnati Post,He didn't figure out the why part until after he learned his father had Parkinson's disease and his brother had chronic myelogenous leukemia.

Troubled PDL sells one of its 3 drugs  -  Dec 18, 2007
San Jose Mercury News,Administration approved in 1999 to help prepare patients to receive bone marrow transplants to treat chronic myelogenous leukemia, a form of cancer.

ASH: Newer Agents Vie for CML Niche in Imatinib Failure  -  Dec 12, 2007
MedPage Today,12 -- Chronic myelogenous leukemia patients who are resistant or intolerant to imatinib (Gleevec) had a high response rate when treated with dasatinib

South Notes: Amy's Army visits college  -  Dec 6, 2007
Pittsburgh Post Gazette,Amy suffers from chronic myelogenous leukemia, a disease that is rare for people her age. She is responding to treatment, but the only cure for her type of

Otsuka to acquire Busulfex rights from PDL BioPharma  -  Dec 19, 2007
Trading Markets (press release),...to allogeneic hematopoietic progenitor cell transplantation (also referred to as blood or bone marrow transplantation) for chronic myelogenous leukemia.

Innovive's cancer drug found effective against CML  -  Dec 11, 2007
Pharmaceutical Business ReviewBy Staff Writer In the study, Inno-406 was shown to be well tolerated and demonstrated activity in patients with chronic myelogenous leukemia (CML) who are

Reduced-Intensity Conditioning Safe with Stem Cell Transplant in CML  -  Dec 11, 2007
Cancerpage.com,...overall survival and allows adequate disease control in chronic myelogenous leukemia (CML), researchers report in the November 1st issue of Blood.

New York State Health Department Approves Busulfan Testing by ...  -  Dec 12, 2007
Business Wire (press release),...used as a preparative regimen prior to allogeneic hematopoeitic stem cell transplant (HSCT) in patients suffering from chronic myelogenous leukemia.

Researcher laments limited governmental funds for cancer projects  -  Dec 3, 2007
Palm Beach Daily News,...for colorectal cancer; and Gleevec, for chronic myelogenous leukemia and gastrointestinal tumors have changed the landscape of cancer treatment.

Manatee school site tests find no contamination  -  Dec 3, 2007
Sarasota Herald-Tribune,Jozsa's sister, Terri Lumsden Jewell, died in 1999 from chronic myelogenous leukemia, which strikes one or two people out of 100000.

Search the web for more resources on

Web health.mongabay.com

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.